DataMeds AI (NASDAQ: MEDS) and closely held Tollo Health have announced the launch of the Health Lives Here mobile application (app), initially focused on supporting users of GLP-1 receptor agonist medications.
According to DataMeds AI the companies intend to expand the target patient populations in the fourth quarter of 2026 to include patients with Long COVID, and later cancer patients. Marketing of the application is being driven through the companies’ partnership with closely held NFL Alumni Health, the health-focused division of the National Football League Alumni Association.
In a statement, Gerald Commissiong, interim co-CEO of DataMEDS, commented, “What patients really want is for healthcare to be as easy to use as the apps they rely on every day. Health Lives Here gives patients one front door to telehealth, their local pharmacist and their own health data, and with NFL Alumni Health, we have messengers who can meet people where they are, including in rural and underserved communities.”
Brad Edwards, CEO of the NFL Alumni Association, remarked, “We are excited to help DataMEDS and Tollo Health launch Health Lives Here, especially to help improve healthcare access for patients in rural communities.”
